Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany.MoreShow less
Profile & Fundamentals
Review the profile, reported financial history, AI financial assessment, dividends, splits, and dated events for Hims & Hers Health.
Profile & Fundamentals
Hims & Hers Health Profile & Fundamentals
Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.
Explore this pageJump to a Profile & Fundamentals section
Explore this research
Profile & Fundamentals contents
Jump directly to any section
Company and Market Context
Company Profile & Ownership
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Company profile record
Hims Hers Health Inc
Common Stock · Healthcare · Drug Manufacturers - Specialty & Generic
Company
- Company / asset
- Hims Hers Health Inc
- Security type
- Common Stock
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- HQ
- 🇺🇸 United States
- Head office
- 2269 Chestnut Street, San Francisco, CA, United States, 94123
Leadership & scale
- Chief executive
- Mr. Andrew Dudum
- CEO year born
- 1988
- Full-time employees
- 2.4K
- Fiscal year end
- December
- IPO date
- 2019-09-13
Fundamentals snapshot
- Market Cap
- USD 6.3B
- P/E
- --
- Revenue (Q1 26)
- USD 608.1M
- Profit (Q1 26)
- USD -92.1M
- Dividend Yield
- --
- Revenue (FY 25)
- USD 2.3B
- Shares in public float
- 210.6M
- Insider ownership
- 5.51%
Reporting & identifiers
- Symbol
- HIMS.NYSE
- Listing
- 🇺🇸 United States | Dividend Tax: 30%
- Ticker Currency
- USD
- Income Statement Currency
- USD
- Balance Sheet Currency
- USD
- Cash Flow Currency
- USD
- EPS Currency
- USD
- Contract Type
- SPOT
- ISIN
- US4330001060
- Asset ID
- equity_66030d24-c4db-5de4-b6cd-c0c5afaa1703
Ownership
Shares Outstanding
Latest: 228.4M | Max: 248.1M | Min: 39.1M
Complete Research Workspace
Unlock the complete Profile & Fundamentals
Sign in to verify your access, or upgrade to the Base plan to open every chart, financial statement, event, and source table.